Gain Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -20 | -20 | ||
EBITDA | -3,309 | -4,437 | -8,162 | -4,371 |
EBIT | -3,331 | -4,458 | -8,182 | -4,391 |
Net Income | -3,768 | -4,485 | -8,143 | -4,014 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,455 | -6,076 | -5,777 | -3,586 |
Cash | 10,385 | 12,049 | 16,936 | 10,641 |
Basic Shares | 24,706 | 26,531 | 19,215 | 17,978 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $55 | $140 | $164 |
Gross Profit | -25 | 75 | -6,999 | |
EBITDA | -20,350 | -22,169 | -17,777 | -13,822 |
EBIT | -22,253 | -17,841 | -13,837 | |
Net Income | -20,411 | -22,267 | -17,590 | -13,890 |
Net Change In Cash | 0 | 55 | 140 | 164 |
Cost of Revenue | -29,545 | |||
Free Cash Flow | -18,896 | -18,881 | -14,811 | -12,459 |
Cash | 10,385 | 11,794 | 7,311 | 36,880 |
Basic Shares | 22,881 | 13,011 | 11,883 | 10,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.08 |
2024-09-30 | -$0.17 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.22 |
